Combined prolonged exposure therapy and paroxetine for PTSD related to the World Trade Center attack: a randomized controlled trial - Test2 - elhamkhani - TriplyDB

Combined prolonged exposure therapy and paroxetine for PTSD related to the World Trade Center attack: a randomized controlled trial

Combined prolonged exposure therapy and paroxetine for PTSD related to the World Trade Center attack: a randomized controlled trial

http://www.wikidata.org/entity/Q23912881

about

Pharmacological enhancement of exposure-based treatment in PTSD: a qualitative review From Pavlov to PTSD: the extinction of conditioned fear in rodents, humans, and anxiety disorders.Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders Targeting memory processes with drugs to prevent or cure PTSD Assessing Treatment-Resistant Posttraumatic Stress Disorder: The Emory Treatment Resistance Interview for PTSD (E-TRIP)Effect of cognitive-behavioral therapy for anxiety disorders on quality of life: a meta-analysis Examining potential contraindications for prolonged exposure therapy for PTSD The effectiveness of cognitive behavioral therapy with respect to psychological symptoms and recovering autobiographical memory in patients suffering from post-traumatic stress disorder Higher in vivo serotonin-1a binding in posttraumatic stress disorder: a PET study with [11C]WAY-100635 Changes in comorbid conditions after prolonged exposure for PTSD: a literature review Individual differences in recovery from traumatic fear Understanding the Relationship between Rainstorm-Related Experiences and PTSD among Chinese Adolescents after Rainstorm Disaster: The Roles of Rumination and Social Support Mental health service use by cleanup workers in the aftermath of the Deepwater Horizon oil spill Combining seeking safety with sertraline for PTSD and alcohol use disorders: A randomized controlled trial Longitudinal relationships between posttraumatic stress symptoms and sleep problems in adolescent survivors following the Wenchuan earthquake in China Is Exposure Necessary? A Randomized Clinical Trial of Interpersonal Psychotherapy for PTSD Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders D-cycloserine for treatment of numbing and avoidance in chronic post traumatic stress disorder: A randomized, double blind, clinical trial PSYCHOTHERAPY VERSUS PHARMACOTHERAPY FOR POSTTRAUMATIC STRESS DISORDER: SYSTEMIC REVIEW AND META-ANALYSES TO DETERMINE FIRST-LINE TREATMENTS.A pharmacotherapeutic approach to the management of chronic posttraumatic stress disorder.Cognitive behavioral treatments for posttraumatic stress disorder: empirical foundation and new directions.Pharmacotherapy in the aftermath of trauma; opportunities in the 'golden hours'.Psychopharmacological strategies in the management of posttraumatic stress disorder (PTSD): what have we learned?9/11-related PTSD among highly exposed populations: a systematic review 15 years after the attack.On the Road to Translation for PTSD Treatment: Theoretical and Practical Considerations of the Use of Human Models of Conditioned Fear for Drug Development.Racial differences in adherence and response to combined treatment for full and subthreshold post-traumatic stress disorder and alcohol use disorders: A secondary analysis Effects of paroxetine on PTSD-like symptoms in mice.Psychotherapy Utilization and Retention in a National Sample of Veterans With PTSD.Two weeks of pretreatment with escitalopram facilitates extinction learning in healthy individuals.Advances and controversies in military posttraumatic stress disorder screening.Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology.

P2860

Q22305514-98324AE3-5835-4E10-AD16-DB7412887FE7 Q26851172-DD969D95-CD86-4BC9-819F-E836C753E51A Q27006437-A015E894-A05D-4F0D-B8E3-704A2B240D04 Q27009995-0312BBD1-24A0-40A9-8497-BC60B6BC8B4C Q27016155-F8B5166B-776B-4288-A907-54E5493C6846 Q28385622-726AAAFD-EC6D-4E79-AE3E-1B921C20BC08 Q28386420-BA90CB18-64C8-4937-94E0-1B18788AB99F Q28386918-86B092B1-B69A-4B80-A675-742FD3E3AB90 Q28388813-2C451A9D-3A6F-45AF-94F6-F38CE4D7F6B4 Q28389170-FB5EE022-F710-4409-848D-15750FC47917 Q28389179-04CA834C-3D9D-4819-AAAA-A640D5FDBEAB Q28389310-29C8504E-029E-4179-A272-B01AF8BC3669 Q28389348-5C2B32D6-2B13-474A-8EBA-74197887CB4A Q28390045-FB64438B-2E63-4081-BAAD-1AF08514FAB8 Q28390909-85E4338B-1047-4ADA-860A-F9497DBDC9A7 Q28391975-712C4FE2-3515-49C2-BFF6-FF09A76961B7 Q28396216-E8EE4EE3-635C-40B1-BC05-BC8FB42E570E Q28396555-220286DD-0E4C-41A5-82AD-6D3019C04CB5 Q28396812-5A017CE7-B824-42F6-A858-911D5BB22E3B Q36002473-CC7B356F-669B-4A4F-899F-D5641702841D Q38006441-0084A613-104D-4185-BF5C-6BC5B43C8015 Q38078551-BC5F893F-F8B1-46C9-929C-31D104944E14 Q38217123-779B2AB7-1167-488A-AD24-A99F2BC7DD21 Q38370133-BBEA7CAC-483D-4295-9F81-37758A7BE6CC Q38626353-82C64DB2-7B6A-467B-84FD-A1786C5DD942 Q38852116-AF4F6BFD-B90D-404A-8FAF-B43FB14543C9 Q40482735-B3CEE1DC-44D8-4A6B-B99A-DD5F6AC76702 Q41587435-7E4CECE3-33AF-4F04-BE1D-86F8C17537E6 Q45326873-8DD8422D-AE9C-4962-B9D5-C1F98E1C7838 Q48008305-4984DA12-FC9B-44E4-92A9-1CE7951695CC Q48254554-9DC06436-9136-4E98-AD3B-EA7234E4863A Q53091817-FFD34CE6-8F96-4191-961F-0FE59BBABF7C

P2860

Combined prolonged exposure therapy and paroxetine for PTSD related to the World Trade Center attack: a randomized controlled trial

http://www.wikidata.org/entity/Q23912881

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Combined prolonged exposure th ...... a randomized controlled trial

@ast

Combined prolonged exposure th ...... a randomized controlled trial

@en

Combined prolonged exposure th ...... a randomized controlled trial

@en-gb

Combined prolonged exposure th ...... a randomized controlled trial

@nl

type

label

Combined prolonged exposure th ...... a randomized controlled trial

@ast

Combined prolonged exposure th ...... a randomized controlled trial

@en

Combined prolonged exposure th ...... a randomized controlled trial

@en-gb

Combined prolonged exposure th ...... a randomized controlled trial

@nl

prefLabel

Combined prolonged exposure th ...... a randomized controlled trial

@ast

Combined prolonged exposure th ...... a randomized controlled trial

@en

Combined prolonged exposure th ...... a randomized controlled trial

@en-gb

Combined prolonged exposure th ...... a randomized controlled trial

@nl

P1433

Q23912881-07FC5632-37E8-4DC5-8865-5A96885322CC

P1476

Q23912881-014F3A2C-3AF0-4222-B76C-B03D86E0CC5D

P2093

Q23912881-4E409202-DD69-462B-9E49-A8CAF1514F1E

Q23912881-61C385E1-B113-48D3-83FC-54F7C2F4E2B3

Q23912881-8B428A50-271F-4AB3-AD3D-40A9B9117434

Q23912881-95F28096-DDCC-472D-9B6E-4C5D485BB779

Q23912881-9A8F8E5D-3BE4-485E-BD58-45ECACB8ADE0

Q23912881-AE6E217D-F0CC-4FAB-9E1B-167C2F5BE583

Q23912881-E248BE1F-B85B-4A4A-9915-184D6533CA76

P2860

Q23912881-03D89F12-DB9C-4A8B-BD8D-CC0979F28509

Q23912881-06ECA9E9-61E1-420B-8231-8DB44210D50C

Q23912881-075C4B5B-5338-44DE-8956-0C07E9F54ABF

Q23912881-0C80FC1C-07AB-4A8E-A1BD-2F97536814F5

Q23912881-24E0B06F-8880-43FB-BB7B-2AF90BA2F343

Q23912881-2B4D395C-C2BB-4923-9C90-8A9CFD84246E

Q23912881-2FD760DF-F1FB-4E33-BC87-6273363485D5

Q23912881-38EF3FA3-AE04-4FBB-9DC2-534DBB372067

Q23912881-44AE5875-86F4-4C7C-A2E7-2F00814B3A87

Q23912881-5B21C2A8-5A3F-44A4-BCA0-19453BFE3E22

P2880

Q23912881-26B69A41-101E-4789-A679-23B8223037F4

P304

Q23912881-433219E7-40A4-4436-A832-FC97E9308B65

P31

Q23912881-18D82F3F-4AE5-4901-B23B-D0CA20200CF0

P3181

Q23912881-0C642017-5D7F-45D9-82DD-32345D5FB65A

P356

Q23912881-A7FD5806-D126-4B7E-ABAA-8B0415892EE5

P407

Q23912881-06704239-8924-4C1F-BAFD-965317741C23

P433

Q23912881-274F4143-94B7-4027-B1CE-5EB036C8DE82

P478

Q23912881-AC57B6BA-B420-4180-B33E-1031B94F31F1

P577

Q23912881-92117354-21AF-4261-91D5-31B5F4D76C04

P5875

Q23912881-5B917DC5-EE09-414C-A1AA-F01DD7425198

P698

Q23912881-96E3503D-6EB4-4D67-8F08-6407E0883544

P859

Q23912881-221BF768-DF2D-487C-8705-D60F06FB7F75

P921

Q23912881-1C6C6B2C-1632-49EF-AE3D-84EF19A73EEB

Q23912881-2587EEFF-7831-4780-8F43-9CEBDD1C2258

Q23912881-84C7B3B1-94CA-481E-BD20-8C335735D0A3

Q23912881-B14B29A7-63B7-4BE8-9865-3AF2B95A9CB0

Q23912881-C7477A79-1A60-4563-BCFD-D9C4BCFAD4AB

Q23912881-F64A858B-AE13-42C4-90B9-A28AC9AB3193

P932

Q23912881-E6EEF753-6C00-44E0-A663-5622EF9541EB

P3181

P356

APPI.AJP.2011.11020321

P1433

American Journal of Psychiatry

P1476

Combined prolonged exposure th ...... a randomized controlled trial

@en

P2093

Elizabeth Hembree

http://www.w3.org/2001/XMLSchema#string

Eun Jung Suh

http://www.w3.org/2001/XMLSchema#string

Franklin R Schneier

http://www.w3.org/2001/XMLSchema#string

Lawrence Amsel

http://www.w3.org/2001/XMLSchema#string

Martina Pavlicova

http://www.w3.org/2001/XMLSchema#string

Randall D Marshall

http://www.w3.org/2001/XMLSchema#string

Yuval Neria

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

Post-traumatic stress disorder following disasters: a systematic review

Development of a rating scale for primary depressive illness

Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study.

Zero-inflated and hurdle models of count data with extra zeros: examples from an HIV-risk reduction intervention trial

Maximizing treatment outcome in post-traumatic stress disorder by combining psychotherapy with pharmacotherapy.

The development of a Clinician-Administered PTSD Scale.

A multidimensional meta-analysis of psychotherapy for PTSD.

Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study.

P2880

20046555

http://www.w3.org/2001/XMLSchema#string

P304

80-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3497768

http://www.w3.org/2001/XMLSchema#string

P356

10.1176/APPI.AJP.2011.11020321

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

169

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51639945

http://www.w3.org/2001/XMLSchema#string

P698

21908494

http://www.w3.org/2001/XMLSchema#string

P859

National Institute for Occupational Safety and Health

P921

health monitoring

post-traumatic stress disorder

psychological stress

P932

3606709

http://www.w3.org/2001/XMLSchema#string